Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
While this class of drugs was initially approved for type 2 diabetes, it has recently gained global attention for cardiovascular risk reduction and weight loss in patients with obesity, irrespective of the presence of diabetes
GLP-1 RAs remain expensive limiting their availability in low- and middle-income countries
Lindell AE, Zimmermann-Kogadeeva M, Patil KR
ADHD is associated with higher rates of obesity, partly due to impulsive eating patterns and partly due to dopaminergic effects on reward processing
2018 Mar;20(3):610-619
:max_bytes(150000):strip_icc()/Health-GettyImages-1675158771-70640c9fdf1b41078975cfc3fd538a6b.jpg)
US$ 25.39
US$ 22.52
US$ 20.78
US$ 20.75
US$ 21.45
